Sonnet Total Stockholder Equity vs Cash Analysis

SONN Stock  USD 2.89  0.03  1.03%   
Sonnet Biotherapeutics financial indicator trend analysis is much more than just breaking down Sonnet Biotherapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sonnet Biotherapeutics is a good investment. Please check the relationship between Sonnet Biotherapeutics Total Stockholder Equity and its Cash accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Stockholder Equity vs Cash

Total Stockholder Equity vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sonnet Biotherapeutics Total Stockholder Equity account and Cash. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Sonnet Biotherapeutics' Total Stockholder Equity and Cash is 0.49. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Cash in the same time period over historical financial statements of Sonnet Biotherapeutics Holdings, assuming nothing else is changed. The correlation between historical values of Sonnet Biotherapeutics' Total Stockholder Equity and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Sonnet Biotherapeutics Holdings are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Total Stockholder Equity i.e., Sonnet Biotherapeutics' Total Stockholder Equity and Cash go up and down completely randomly.

Correlation Coefficient

0.49
Relationship DirectionPositive 
Relationship StrengthWeak

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Cash

Cash refers to the most liquid asset of Sonnet Biotherapeutics, which is listed under current asset account on Sonnet Biotherapeutics Holdings balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Sonnet Biotherapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Sonnet Biotherapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from Sonnet Biotherapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sonnet Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
As of the 22nd of November 2024, Tax Provision is likely to grow to about 69.7 K, while Selling General Administrative is likely to drop about 2.4 M.

Sonnet Biotherapeutics fundamental ratios Correlations

0.810.870.820.70.190.280.450.71-0.10.240.560.190.880.160.73-0.37-0.120.13-0.090.13-0.17-0.280.580.35-0.62
0.810.890.390.810.40.720.180.84-0.070.020.790.090.95-0.320.92-0.2-0.09-0.34-0.12-0.34-0.43-0.240.50.17-0.5
0.870.890.520.730.260.50.360.74-0.010.410.620.410.96-0.050.86-0.28-0.38-0.1-0.26-0.1-0.04-0.40.720.32-0.66
0.820.390.520.39-0.04-0.170.390.36-0.150.260.140.140.470.510.43-0.370.050.49-0.070.49-0.06-0.110.270.39-0.39
0.70.810.730.390.40.660.310.98-0.40.070.83-0.140.77-0.380.730.230.17-0.390.02-0.39-0.46-0.290.530.42-0.58
0.190.40.26-0.040.40.19-0.240.420.370.010.720.10.37-0.050.30.41-0.090.00.280.0-0.3-0.20.32-0.09-0.51
0.280.720.5-0.170.660.190.00.69-0.24-0.290.64-0.210.6-0.880.67-0.030.13-0.89-0.01-0.89-0.55-0.020.130.07-0.12
0.450.180.360.390.31-0.240.00.3-0.390.270.090.040.320.140.08-0.17-0.070.09-0.060.090.25-0.40.350.3-0.23
0.710.840.740.360.980.420.690.3-0.4-0.010.88-0.150.81-0.40.730.220.16-0.41-0.06-0.41-0.49-0.30.570.31-0.62
-0.1-0.07-0.01-0.15-0.40.37-0.24-0.39-0.40.27-0.080.580.010.3-0.1-0.28-0.610.30.230.30.30.290.08-0.20.0
0.240.020.410.260.070.01-0.290.27-0.010.27-0.120.750.20.480.12-0.06-0.690.42-0.20.420.56-0.410.620.52-0.41
0.560.790.620.140.830.720.640.090.88-0.08-0.12-0.10.77-0.390.590.280.04-0.370.13-0.37-0.48-0.270.550.04-0.63
0.190.090.410.14-0.140.1-0.210.04-0.150.580.75-0.10.250.440.2-0.29-0.950.37-0.20.370.62-0.320.43-0.03-0.21
0.880.950.960.470.770.370.60.320.810.010.20.770.25-0.170.83-0.28-0.27-0.2-0.09-0.2-0.21-0.350.670.22-0.65
0.16-0.32-0.050.51-0.38-0.05-0.880.14-0.40.30.48-0.390.44-0.17-0.28-0.16-0.320.99-0.090.990.54-0.160.170.03-0.17
0.730.920.860.430.730.30.670.080.73-0.10.120.590.20.83-0.28-0.22-0.11-0.3-0.3-0.3-0.38-0.20.360.22-0.41
-0.37-0.2-0.28-0.370.230.41-0.03-0.170.22-0.28-0.060.28-0.29-0.28-0.16-0.220.29-0.12-0.01-0.12-0.16-0.090.13-0.02-0.17
-0.12-0.09-0.380.050.17-0.090.13-0.070.16-0.61-0.690.04-0.95-0.27-0.32-0.110.29-0.250.16-0.25-0.640.32-0.490.120.18
0.13-0.34-0.10.49-0.390.0-0.890.09-0.410.30.42-0.370.37-0.20.99-0.3-0.12-0.25-0.071.00.48-0.120.130.01-0.16
-0.09-0.12-0.26-0.070.020.28-0.01-0.06-0.060.23-0.20.13-0.2-0.09-0.09-0.3-0.010.16-0.07-0.07-0.10.11-0.260.10.16
0.13-0.34-0.10.49-0.390.0-0.890.09-0.410.30.42-0.370.37-0.20.99-0.3-0.12-0.251.0-0.070.48-0.120.130.01-0.16
-0.17-0.43-0.04-0.06-0.46-0.3-0.550.25-0.490.30.56-0.480.62-0.210.54-0.38-0.16-0.640.48-0.10.48-0.190.18-0.09-0.05
-0.28-0.24-0.4-0.11-0.29-0.2-0.02-0.4-0.30.29-0.41-0.27-0.32-0.35-0.16-0.2-0.090.32-0.120.11-0.12-0.19-0.49-0.130.45
0.580.50.720.270.530.320.130.350.570.080.620.550.430.670.170.360.13-0.490.13-0.260.130.18-0.490.35-0.81
0.350.170.320.390.42-0.090.070.30.31-0.20.520.04-0.030.220.030.22-0.020.120.010.10.01-0.09-0.130.35-0.35
-0.62-0.5-0.66-0.39-0.58-0.51-0.12-0.23-0.620.0-0.41-0.63-0.21-0.65-0.17-0.41-0.170.18-0.160.16-0.16-0.050.45-0.81-0.35
Click cells to compare fundamentals

Sonnet Biotherapeutics Account Relationship Matchups

Sonnet Biotherapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets29.8M8.0M29.0M5.8M5.4M28.3M
Short Long Term Debt Total10.3M353.3K125.9K256.0K203.9K9.8M
Total Current Liabilities13.0M4.7M6.7M8.2M5.5M12.4M
Total Stockholder Equity7.4M3.0M22.3M(2.5M)(226.0K)8.9M
Property Plant And Equipment Net9.8M273.8K182.3K302.8K227.1K10.2M
Net Debt9.8M(7.0M)(27.5M)(2.8M)(2.1M)9.3M
Accounts Payable2.4M2.1M3.8M4.8M2.2M2.3M
Non Current Assets Total28.4M356.8K182.3K416.1K691.2K27.0M
Liabilities And Stockholders Equity29.8M8.0M29.0M5.8M5.4M28.3M
Non Current Liabilities Total8.5M250.0K30.6K203.9K130.9K8.1M
Other Stockholder Equity64.1M39.7M83.9M88.9M110.0M60.9M
Total Liab21.5M5.0M6.7M8.4M5.7M20.5M
Total Current Assets1.3M7.6M28.8M5.4M4.7M1.3M
Short Term Debt6.7M103.2K95.3K52.1K73.0K6.3M
Common Stock373.01.5K6.0K554.0175.0354.35
Retained Earnings(57.1M)(36.7M)(61.7M)(91.4M)(110.2M)(60.0M)
Cash524.1K7.3M27.6M3.1M2.3M497.9K
Non Currrent Assets Other2.9M83.0K(182.3K)113.3K464.2K2.7M
Cash And Short Term Investments524.1K7.3M27.6M3.1M2.3M497.9K
Other Current Assets159.2K575.5K2.4M4.0M1.7M151.2K
Other Current Liab2.8M2.1M2.3M3.2M3.2M2.7M
Common Stock Shares Outstanding439.5830.6K79.7K197.5K1.0M417.6
Property Plant And Equipment Gross9.8M273.8K182.3K302.8K227.1K5.3M
Net Tangible Assets7.4M3.0M22.3M(2.5M)8.5M9.0M
When determining whether Sonnet Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonnet Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonnet Biotherapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonnet Biotherapeutics Holdings Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.96)
Revenue Per Share
0.019
Quarterly Revenue Growth
(0.50)
Return On Assets
(0.97)
Return On Equity
(2.65)
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.